Loading the records…
Loading the records…
HR1806 is a procedural, early-stage House bill that directs federal research and education efforts for triple-negative breast cancer but authorizes no specific funding, creates no procurement programs, and imposes no mandates on public companies. It has zero immediate market impact.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No market implications. This bill does not affect revenue, costs, or competitive positioning for any publicly traded company. The legislation is procedural and stalled. Investors should not allocate capital based on this event.
What happened: On March 3, 2025, Rep. Morelle (D-NY) introduced HR1806, the Triple-Negative Breast Cancer Research and Education Act of 2025. The bill was referred to the House Committee on Energy and Commerce — its first and only action to date. It remains in early-stage committee review with no further legislative activity in the 13 months since introduction.
The money trail: The bill authorizes NO specific funding amount. It directs the Secretary of Health and Human Services to expand research and public education programs through existing NIH/CDC authorities, but does not appropriate any new money. This is a classic authorization-only bill — any actual spending would require a separate appropriations bill. Since no funding is authorized, there is no procurement mechanism, no grant program with a dollar figure, and no revenue stream created for any company.
Structural winners and losers: There are none. The bill neither names any company nor creates a mechanism that would differentially affect any publicly traded entity. Potential future beneficiaries of expanded research funding (e.g., diagnostic companies like $EXAS, $GH, or $ILMN) are not mentioned, and the bill does not establish a program from which they could directly contract. Without a funding authorization, there is no binding commitment.
Competitive landscape: No market data is provided or relevant. The bill has zero structural impact on competitive positioning in the healthcare sector.
Timeline: The bill has been stalled in committee for over a year with no hearings, markups, or companion Senate bill. With only 12 cosponsors and a sponsor who is a junior member (not a committee chair), passage in its current form is unlikely in the 119th Congress. The typical path would require committee hearings, a floor vote, Senate introduction and passage, and presidential signature — all absent here.
Matched on shared policy language across AI analyses, with ticker & timing weight
Reducing Hereditary Cancer Act
PREEMIE Reauthorization Act of 2025
Genomic Answers for Children’s Health Act of 2026
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Benay Taub Lung Cancer Research Act
To support biotechnology education for secondary school students, and for other purposes.
MERCK SHARP & DOHME LLC: $2.0B Department of Health and Human Services Contract Vehicle
UTAH DEPARTMENT OF HEALTH AND HUMAN SERVICES: $3.4B Department of Health and Human Services Grant
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →